Your browser is no longer supported. Please, upgrade your browser.
Settings
IBIO iBio, Inc. daily Stock Chart
IBIO [NYSE]
iBio, Inc.
Index- P/E- EPS (ttm)-1.56 Insider Own46.10% Shs Outstand19.02M Perf Week6.30%
Market Cap16.07M Forward P/E- EPS next Y- Insider Trans79.50% Shs Float9.13M Perf Month-2.87%
Income-16.40M PEG- EPS next Q- Inst Own7.50% Short Float7.46% Perf Quarter0.60%
Sales0.40M P/S40.18 EPS this Y6.20% Inst Trans- Short Ratio4.31 Perf Half Y-50.21%
Book/sh1.37 P/B0.62 EPS next Y- ROA-46.00% Target Price3.00 Perf Year-73.90%
Cash/sh0.84 P/C1.01 EPS next 5Y- ROE-190.20% 52W Range0.60 - 3.86 Perf YTD-52.29%
Dividend- P/FCF- EPS past 5Y-4.20% ROI-34.40% 52W High-78.08% Beta0.16
Dividend %- Quick Ratio8.00 Sales past 5Y-15.10% Gross Margin- 52W Low40.81% ATR0.09
Employees7 Current Ratio8.00 Sales Q/Q0.00% Oper. Margin- RSI (14)49.47 Volatility10.36% 10.90%
OptionableNo Debt/Eq1.55 EPS Q/Q22.80% Profit Margin- Rel Volume0.49 Prev Close0.87
ShortableYes LT Debt/Eq1.54 EarningsOct 26 BMO Payout- Avg Volume158.08K Price0.85
Recom- SMA20-4.70% SMA503.93% SMA200-41.03% Volume98,339 Change-2.87%
Oct-02-18 08:00AM  iBio and CC-Pharming Hold First Design and Strategy Meeting GlobeNewswire +13.53%
Aug-22-18 04:10PM  iBio, Inc. Announces NYSE American Acceptance of Plan of Compliance GlobeNewswire
Jul-09-18 08:00AM  iBio Establishes Strategic Commercial Relationship with CC-Pharming Ltd. of Beijing, China GlobeNewswire +8.00%
Jun-27-18 07:20AM  Free Technical Research on Nektar Therapeutics and Three More Biotech Equities ACCESSWIRE
Jun-26-18 06:59PM  iBio, Inc. Closes $16,000,000 Public Offering GlobeNewswire
Jun-22-18 07:26AM  iBio, Inc. Prices $16,000,000 Public Offering GlobeNewswire
Jun-08-18 04:30PM  iBio, Inc. Announces Completion of 1-For-10 Reverse Stock Split GlobeNewswire
04:01PM  iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan GlobeNewswire
Jun-05-18 08:30AM  iBio and ONEWAY Diagnostica Develop New Products for Brazil GlobeNewswire +10.21%
Jun-04-18 05:46PM  Why iBio Incs (NYSEMKT:IBIO) Ownership Structure Is Important Simply Wall St.
May-31-18 08:30AM  iBio, Inc. Announces Reverse Stock Split GlobeNewswire -7.40%
May-24-18 07:15AM  Complimentary Technical Snapshots on Heat Biologics and Three More Biotech Stocks ACCESSWIRE
Apr-11-18 01:27PM  Should iBio Incs (NYSEMKT:IBIO) Recent Earnings Decline Worry You? Simply Wall St. -9.57%
Mar-14-18 08:30AM  iBio Selects Lead Candidate for its Fibrosis Therapeutics Program GlobeNewswire
Mar-12-18 08:30AM  iBio Patent Issues in China on Protein Glycosylation Modification GlobeNewswire
Mar-07-18 08:45AM  iBio Expands Antibody Development and Production Services to Include Fc Fusion Therapeutics GlobeNewswire +26.09%
Dec-18-17 03:44PM  ETFs with exposure to iBio, Inc. : December 18, 2017 Capital Cube +5.91%
Dec-08-17 02:53PM  iBio Inc (IBIO): Does -31.1% EPS Decline Lately Make It An Underperformer? Simply Wall St.
01:03PM  ETFs with exposure to iBio, Inc. : December 8, 2017 Capital Cube
Nov-30-17 04:15PM  iBio, Inc. Closes $4,500,000 Offering of Common Stock GlobeNewswire
Nov-29-17 09:00AM  iBio, Inc. Prices $4,500,000 Firm Commitment Offering of Common Stock GlobeNewswire -31.61%
Nov-28-17 05:07PM  iBio, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire
Nov-27-17 02:12PM  ETFs with exposure to iBio, Inc. : November 27, 2017 Capital Cube
Nov-14-17 02:27PM  ETFs with exposure to iBio, Inc. : November 14, 2017 Capital Cube
Nov-13-17 09:20AM  iBio, Inc. :IBIO-US: Earnings Analysis: Q1, 2018 By the Numbers : November 13, 2017 Capital Cube
Nov-08-17 12:00PM  AEMD: Upcoming FDA Meeting Expected to Define U.S. Regulatory Pathway Zacks Small Cap Research
Nov-06-17 05:00PM  iBio, Inc. Initiates Litigation Against Fraunhofer-Gesellschaft in Delaware Chancery Court GlobeNewswire
Oct-30-17 08:30AM  iBio CDMO President to Co-Chair South African Molecular Pharming Conference GlobeNewswire
Oct-24-17 09:39AM  ETFs with exposure to iBio, Inc. : October 24, 2017 Capital Cube -5.51%
Oct-23-17 08:00AM  IBio, Aethlon Agreement, The Biologics Market, and Analysts Target, CFB-03 Update ACCESSWIRE
Oct-18-17 07:00AM  Featured Company News - iBio Announces Large-Scale Manufacturing Collaboration with Aethlon Medical ACCESSWIRE
Oct-16-17 07:15AM  iBio Announces Manufacturing Collaboration with Aethlon Medical GlobeNewswire +5.00%
07:15AM  Aethlon Medical Announces Large-Scale Production Collaboration PR Newswire
Oct-13-17 10:56AM  ETFs with exposure to iBio, Inc. : October 13, 2017 Capital Cube
Oct-05-17 05:36PM  What Are The Drivers Of iBio Incs (IBIO) Risks? Simply Wall St.
Oct-04-17 09:00AM  iBio, Inc. :IBIO-US: Earnings Analysis: Q4, 2017 By the Numbers : October 4, 2017 Capital Cube
Oct-02-17 10:54AM  ETFs with exposure to iBio, Inc. : October 2, 2017 Capital Cube
08:30AM  iBio Appoints James Abbey, Ph.D. as Vice President of Strategic Business Development GlobeNewswire
Sep-20-17 05:40PM  ETFs with exposure to iBio, Inc. : September 20, 2017 Capital Cube +18.81%
08:00AM  iBio, Inc. Intellectual Property Update GlobeNewswire
Sep-19-17 05:55PM  iBio Makes NYSE MKT Section 610(b) Public Announcement GlobeNewswire -11.35%
02:27PM  iBio, Inc. :IBIO-US: Earnings Analysis: 2017 By the Numbers : September 19, 2017 Capital Cube
Sep-18-17 08:00AM  iBio and TheoremDx Collaborate to Develop Proteins for Rapid Diagnostics Testing Products GlobeNewswire +22.84%
Jul-25-17 07:12AM  AzarGen Biotechnologies Granted European Patent for Plant-Made PRODUCTION OF RECOMBINANT HUMAN SURFACTANT PROTEIN-B PR Newswire +24.24%
Jul-24-17 08:30AM  iBio, Inc. Enters into Common Stock Purchase Agreement for Up to $16.0 Million with Lincoln Park Capital GlobeNewswire -13.55%
Jul-12-17 01:00PM  Wednesdays Biotech Movers: Ibio Inc (IBIO) Rallies, Ocular Therapeutix Inc (OCUL) Tumbles, Alder Biopharmaceuticals Inc (ALDR) Dives SmarterAnalyst +13.57%
08:32AM  US Patent Granted to AzarGen Biotechnologies for Synthetic Promoter Technology PR Newswire
Jul-10-17 02:38PM  ETFs with exposure to iBio, Inc. : July 10, 2017 Capital Cube
Jun-05-17 02:21PM  ETFs with exposure to iBio, Inc. : June 5, 2017 Capital Cube +9.06%
08:30AM  iBio, Inc. to Present Plant-Made Pharmaceutical Platform at Plant-Based Vaccines, Antibodies & Biologics Conference GlobeNewswire
May-25-17 12:41PM  ETFs with exposure to iBio, Inc. : May 25, 2017 Capital Cube
May-24-17 10:27AM  iBio, Inc. :IBIO-US: Earnings Analysis: Q3, 2017 By the Numbers : May 24, 2017 Capital Cube
May-04-17 04:01PM  iBio, Inc. Provides Corporate Update at Annual Shareholders Meeting Marketwired
Apr-25-17 03:36PM  ETFs with exposure to iBio, Inc. : April 25, 2017 Capital Cube
Apr-07-17 04:50PM  ETFs with exposure to iBio, Inc. : April 7, 2017 Capital Cube
Mar-27-17 03:59PM  ETFs with exposure to iBio, Inc. : March 27, 2017 Capital Cube
03:59PM  ETFs with exposure to iBio, Inc. : March 27, 2017
Mar-20-17 12:08PM  iBio, Inc. :IBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : March 20, 2017 Capital Cube
12:08PM  iBio, Inc. :IBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : March 20, 2017
Mar-06-17 05:01PM  IBIO, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Feb-25-17 01:04PM  IBIO, INC. Financials
Feb-24-17 05:04PM  IBIO, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Ma
Feb-21-17 04:06PM  IBIO, INC. Files SEC form 10-Q, Quarterly Report
Jan-27-17 08:30AM  Court Schedules Hearing To Consider Approval Of Settlement Of Derivative Action Marketwired
Jan-25-17 01:18PM  ETFs with exposure to iBio, Inc. : January 25, 2017 Capital Cube +5.21%
01:18PM  ETFs with exposure to iBio, Inc. : January 25, 2017
Jan-04-17 11:06AM  ETFs with exposure to iBio, Inc. : January 4, 2017 +16.18%
Dec-21-16 12:26PM  ETFs with exposure to iBio, Inc. : December 21, 2016 Capital Cube -7.50%
12:26PM  ETFs with exposure to iBio, Inc. : December 21, 2016
Dec-09-16 12:19PM  ETFs with exposure to iBio, Inc. : December 9, 2016 Capital Cube
12:19PM  ETFs with exposure to iBio, Inc. : December 9, 2016
Dec-08-16 08:14AM  iBio, Inc. :IBIO-US: Earnings Analysis: Q1, 2017 By the Numbers : December 8, 2016 Capital Cube
08:14AM  iBio, Inc. :IBIO-US: Earnings Analysis: Q1, 2017 By the Numbers : December 8, 2016
Nov-21-16 08:31AM  Another iBio Plague Vaccine Patent Issues Marketwired -5.86%
Nov-18-16 05:06PM  IBIO, INC. Files SEC form 10-Q, Quarterly Report
Nov-10-16 08:31AM  iBio Expands Product Development Capacity of cGMP Plant Marketwired
Nov-07-16 12:32PM  ETFs with exposure to iBio, Inc. : November 7, 2016 Capital Cube
12:32PM  ETFs with exposure to iBio, Inc. : November 7, 2016
Oct-25-16 02:48PM  ETFs with exposure to iBio, Inc. : October 25, 2016 Capital Cube
02:48PM  ETFs with exposure to iBio, Inc. : October 25, 2016
Oct-24-16 09:10AM  iBio, Inc. :IBIO-US: Earnings Analysis: 2016 By the Numbers : October 24, 2016
Oct-13-16 04:07PM  IBIO, INC. Files SEC form 10-K, Annual Report
Sep-29-16 08:30AM  iBio Proprietary Technology Advances Neonatal Respiratory Distress Syndrome Drug Development for South African Biotech Company AzarGen Biotechnologies (Pty) Ltd Marketwired
Aug-15-16 08:30AM  Implications of Court Decision in Favor of iBio Against Fraunhofer Marketwired
Aug-04-16 08:31AM  iBio, Inc.'s Claims Against Fraunhofer Affirmed by Delaware Chancery Court Marketwired
Jul-05-16 08:31AM  iBio, Inc. Receives FDA Orphan Drug Designation for Fibrosis Product Candidate Marketwired
Jun-29-16 08:31AM  iBio, Inc. Receives New Patent for Its Biotherapeutic Products for Treatment of Fibrosis Marketwired
Jun-07-16 08:31AM  Texas A&M University System and iBio Execute Joint Development Agreement for Plant-Produced Pharmaceuticals Marketwired
May-23-16 04:46PM  IBIO, INC. Files SEC form 10-Q, Quarterly Report
Apr-08-16 06:04AM  IBIO, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financi
Apr-07-16 05:46PM  iBio, Inc. Holds Annual Meeting in College Station, Texas Marketwired
Mar-02-16 04:04PM  IBIO, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Feb-26-16 12:28PM  iBio, Inc. Earnings Analysis: Q2, 2016 By the Numbers
Feb-22-16 06:04AM  IBIO, INC. Files SEC form 10-Q, Quarterly Report
Feb-01-16 12:08PM  Largest Insiders' Trades of the Last Week
Jan-29-16 04:10PM  IBIO, INC. Files SEC form 8-K, Shareholder Director Nominations, Other Events
Jan-14-16 09:08AM  IBIO, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Re
09:00AM  iBio Forms Joint Venture CMO for Large-Scale Pharmaceuticals Manufacturing in Green Plants and Accepts Additional Investment Marketwired
Jan-08-16 08:00AM  The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of iBio, Inc. -- IBIO GlobeNewswire
Dec-16-15 10:52AM  iBio, Inc. Earnings Analysis: Q1, 2016 By the Numbers
iBio, Inc., a biotechnology company, provides product development and manufacturing services to clients, collaborators, and third-party customers in the United States and internationally. The company's services cover the stages of product selection, regulatory approval, and commercial product launch. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. It is also developing vaccine candidates for third parties. The company has collaboration agreements with ONEWAY Diagnostica; AzarGen Biotechnologies (Pty) Ltd; The Texas A&M University System; and Fraunhofer Center for Molecular Biotechnology, as well as strategic relationship with CC-Pharming Ltd. In addition, it offers a range of product and process development, analytical, and manufacturing services. iBio, Inc. is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Eastern Capital LTD10% OwnerJul 12Buy0.902,200,0001,980,0008,457,734Jul 13 04:06 PM
Eastern Capital LTD10% OwnerJun 26Buy0.901,683,3341,515,0016,257,734Jun 28 06:03 PM
Eastern Capital LTD10% OwnerNov 30Buy0.2012,000,0002,400,00045,744,000Dec 04 05:14 PM